Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,510.40
(
0.80%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
107.22
(
-1.25%
)
Bitcoin
66,373.15
(
-0.49%
)
News Focus
News Focus
Post# of 257314
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 210004

Monday, 04/10/2017 11:50:17 AM

Monday, April 10, 2017 11:50:17 AM

Post# of 257314
ABT withdraws ABSORB stent from EU market (with limited exceptions):

http://epvantage.com/Universal/View.aspx?type=Story&id=699747&isEPVantage=yes

This is a rare commercial setback for ABT, who invested a lot in the development of ABSORB and the bioabsorbable-stent technology on which it is based. Although ABSORB is still on the market in the US, the sales are apt to be small following the data reported in #msg-129683267.

ABT is trading flat today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today